Fulminant type 1 diabetes developed after influenza split vaccination

Area of Science:

• Immunology
• Endocrinology
• Virology

Background:

• Fulminant type 1 diabetes (FT1D) is a severe form of diabetes with rapid beta-cell destruction and hyperglycemia.
• The exact pathogenesis of FT1D is not fully understood, but viral infections and genetic factors are implicated.
• Immune checkpoint inhibitor use has also been linked to FT1D development.

Purpose of the Study:

• To investigate a potential link between influenza vaccination and the onset of fulminant type 1 diabetes.
• To explore the immunological mechanisms by which influenza vaccination might induce FT1D.

Main Methods:

• Case report of a 51-year-old Japanese man diagnosed with DKA and FT1D.
• Analysis of patient's medical history, including prior influenza infections and recent influenza vaccination.
• Review of immunological mechanisms potentially involved in FT1D pathogenesis.

Main Results:

• The patient developed DKA associated with FT1D 12 days after receiving an inactive split influenza vaccine.
• The patient had a history of influenza infections and non-susceptible HLA class II genotypes.
• The study proposes that inactive split influenza vaccines might induce FT1D by promoting the redifferentiation of memory CD8-positive T cells into cytotoxic T cells.

Conclusions:

• Inactive split influenza vaccines may trigger fulminant type 1 diabetes in susceptible individuals.
• The mechanism may involve the activation and redifferentiation of memory CD8-positive T cells into cytotoxic T cells.
• This case highlights a potential adverse effect of influenza vaccination on glucose metabolism in specific contexts.